The Supreme Court upheld (6 to 3) a patient's right to sue drug companies in state courts. Wyeth v. Levine involved a woman who received an injection which resulted in gangrene and the loss of a limb and her career as a musician. Warnings for the procedure were insufficient. The decision has extensive consequences for label warnings and consumer protection. States have recently ruled in cases involving disclosure and labeling for antipsychotic drugs.
